The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy

Acta Ophthalmol. 2014 Sep;92(6):e488-90. doi: 10.1111/aos.12392. Epub 2014 Apr 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Central Serous Chorioretinopathy / diagnosis
  • Central Serous Chorioretinopathy / drug therapy*
  • Central Serous Chorioretinopathy / metabolism
  • Chronic Disease
  • Eplerenone
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Receptors, Mineralocorticoid / metabolism
  • Spironolactone / analogs & derivatives*
  • Spironolactone / therapeutic use
  • Subretinal Fluid
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Visual Acuity / physiology

Substances

  • Mineralocorticoid Receptor Antagonists
  • Receptors, Mineralocorticoid
  • Spironolactone
  • Eplerenone